Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer HealthCare’s Qidong Company Receives New Drug Production License

This article was originally published in PharmAsia News

Executive Summary

Bayer HealthCare has almost finalized its acquisition of Topsun Science and Technology's Black and White cold medicine, and a drug production license has been granted to the new Qidong company. It will receive an official business license after obtaining the relevant drug approval numbers. The two parties will complete transfer procedures of GMP authentication and drug registration certification at the end of June. Even after selling off its popular OTC medicine, Topsun's losses still total some 880 million yuan ($124 million), but its liquidity status will be improved. Officials say the firm will focus on its stalwart traditional Chinese medicine core, modern TCM, as well as narcotic and psychotropic drugs in the future. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068917

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel